Starboard Value’s TriSalus Life Sciences TLSI Stock Holding History

Starboard Value’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-298,368	Closed	-$2.96M	–	154
2022 Q3	$2.96M	Hold	298,368	–	–	0.07%	129
2022 Q2	$2.94M	Hold	298,368	–	–	0.05%	136
2022 Q1	$2.92M	Hold	298,368	–	–	0.04%	125
2021 Q4	$2.95M	Sell	298,368 -76,632	-20%	-$761K	0.04%	96
2021 Q3	$3.72M	Buy	375,000 +225,000	+150%	+$2.2M	0.07%	44
2021 Q2	$1.46M	Buy	+150,000	New	+$1.47M	0.03%	55

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Starboard Value's TLSI Position: Q4 2022 in Review

Starboard Value sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 298,368 shares — an estimated $2.96M sold.

Starboard Value first reported a position in TLSI in Q2 2021 and held it in 6 quarters. The position peaked at $3.72M in Q3 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

Starboard Value reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
Starboard Value sold 298,368 TriSalus Life Sciences shares in Q4 2022, an estimated $2.96M.
Starboard Value first reported a position in TriSalus Life Sciences in Q2 2021 and held it in 6 quarters.
Starboard Value's TriSalus Life Sciences position peaked at $3.72M in Q3 2021.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Starboard Value's 13F filing for Q4 2022, filed 14 Feb 2023.